Our multi-disciplinary team offers best in class health economics and outcomes research (HEOR) and market access services to the world’s leading pharmaceutical and medical device companies. We balance scientific rigor with commercial awareness, differentiating ourselves from our competition through innovation, technical excellence, and design.
To find out more about the market access roadmap service please get in touch
Our in-house team of strategists, health economists, researchers, medical writers, systematic reviewers, statisticians, designers, developers, and project managers allows you to achieve all aspects of your HEOR and market access goals, eliminating the need to commission several different agencies.
DRG is participating in the online career fair organised by HealthEconomics.com this Wednesday, 31st January 2018 from 11.00am – 2.00 pm Eastern Time. A career at DRG means working among the brightest an...
Patients with very rare diseases, in addition to the consequences of their disease, also suffer at the hands of market forces. The cost of developing drugs is high, and there is a small market for drugs for rar...
We are part of Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd.
DRG offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 1,000 employees across 17 offices in North America, Europe and Asia.Our Company